Research progress in clinical management of nonalcoholic fatty liver disease
10.3969/j.issn.1671-8348.2024.05.023
- VernacularTitle:非酒精性脂肪性肝病临床管理的研究进展
- Author:
Yajun QIN
1
;
Haiyang PENG
;
Yan LIU
;
Jianping GONG
Author Information
1. 重庆医科大学附属第二医院肝胆外科,重庆 400010
- Keywords:
non-alcoholic fatty liver disease;
diagnosis;
clinical protocols;
clinical management;
review
- From:
Chongqing Medicine
2024;53(5):766-771
- CountryChina
- Language:Chinese
-
Abstract:
Nonalcoholic fatty liver disease(NAFLD),also known as metabolic associated fatty liver disease(MAFLD),is one of the most common chronic liver diseases characterized by the fat accumulation in the liver and hepatocellular damage.Patients with NAFLD can manifest as simple fatty liver or non-alcoholic steatohepatitis(NASH)in the early stage,and can progress to hepatic fibrosis,hepatic cirrhosis,hepatic fail-ure,and hepatic carcinoma in the late stage.NAFLD has become the most common chronic liver disease,af-fecting more than 30%of the population worldwide,posing a threat to human health that cannot be ignored.However,the current research on NAFLD is still incomplete,and there is no ideal medication for the treat-ment of NAFLD.The clinical management of NAFLD lacks unified standards and evidence-based evidence,and the multiple comorbidities bring challenges to the clinical management of NAFLD.This article was aimed to review the research progress in the clinical management of NAFLD,including the diagnosis and non-invasive examination methods,evaluation and commonly used tools,treatments methods,advantages and disadvanta-ges,so as to provide a reference for the clinical management of NAFLD.
